Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and IP Carboplatin in Ovarian/Peritoneal/Fallopian Tube Cancer
NCT00369954Phase 2Withdrawn
- Sponsor
- GOG Foundation
- Start
- Apr 2006
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of gemcitabine, carboplatin in ovarian epithelial cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by GOG Foundation. Planned start Apr 2006; status: withdrawn.
02
Drugs
gemcitabinecarboplatin
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00369954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369954.